Let's see what's the hype about
US$ 29.90
which glp 1 drugs are approved for obesity Indications GLP-1/GIP RA Summary Sheet and Beyond! From Fat Burn to Muscle
Description
A large international study published in The Lancet Psychiatry suggests that GLP-1 receptor agonists used for diabetes and weight loss are linked to a lower risk of worsening mental health in people with existing anxiety or depression
Teasing out the different mechanisms at play and the subsequent effects on dementia risk is going to take a while
The result is a market with enormous demand, high willingness to pay, and longstanding dissatisfaction
Accessed February 5, 2020
Clin Res Cardiol
55:835-847 [PubMed: 20110146] 87
